Here are 10 important issues to consider when handling workplace harassment complaints.
Overprescribing by just one practitioner can lead to an untoward outcome that may readily affect the entire healthcare facility.
If signed into law, Trump’s tax reform will have substantive impacts on healthcare organizations and on individuals.
The key changes the Trump Administration has made that could make it more difficult for consumers to sign up for healthcare coverage.
PBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
The Trump Administration issued two rules rolling back the federal requirement that employers include birth control coverage in their group health plans. Here’s what you need to know.
Payers’ biggest concerns for 2018, health insurance exchange participation plans, and how offerings could change.
FDA incentives have hastened the development of “orphan drugs” for rare diseases, but some worry that regulators are not always demanding clear evidence for drug efficacy.
New healthcare terms and topics constantly crop up. Here are six to keep an eye on right now.
Experts share how the declaration could affect how the opioid epidemic is managed.